Cargando…

The Primary Goal of Anticoagulation in Atrial Fibrillation to Prevent Stroke and Not to Offer the Apparently Cheapest Treatment

Detalles Bibliográficos
Autor principal:	Diener, Hans-Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Stroke Society 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060275/ https://www.ncbi.nlm.nih.gov/pubmed/24949309 http://dx.doi.org/10.5853/jos.2014.16.2.57

Ejemplares similares

The Cheapest Antiseptic
Publicado: (1885)

The Cheapest Disinfectant
por: Druitt, Robert
Publicado: (1864)

Cheapest Food
Publicado: (1857)

Cheapest Food
Publicado: (1882)

Cheapest Food
Publicado: (1880)

Cheapest Food
Publicado: (1877)

The Cheapest Disinfectant
por: Druitt, Robert
Publicado: (1864)

Stroke prevention within primary care: management of atrial fibrillation using oral anticoagulation
por: Lotufo, Paulo Andrade
Publicado: (2018)

Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin
por: Ansell, Jack
Publicado: (2017)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Preventing stroke in atrial fibrillation patients – clinical utility of oral anticoagulants
por: Jhawar, Manish B, et al.
Publicado: (2012)

Homebuying tips on how to get the world's cheapest loan
por: Warren, Carolyn, et al.
Publicado: (2010)

Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
por: Rasmussen, Lars Hvilsted, et al.
Publicado: (2012)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients
por: Scanavacca, Maurício, et al.
Publicado: (2016)

Stroke prevention with rivaroxaban in higher‐risk populations with atrial fibrillation
por: Diener, H.‐C., et al.
Publicado: (2015)

Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
por: Chang, Ting-Yung, et al.
Publicado: (2018)

Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable
por: Barnes, Geoffrey D., et al.
Publicado: (2022)

Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation
por: Meinel, Thomas R., et al.
Publicado: (2020)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
por: Kapadia, Meera, et al.
Publicado: (2023)

Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
por: Sabbag, Avi, et al.
Publicado: (2018)

Stroke Prevention in Atrial Fibrillation: Understanding the New Oral Anticoagulants Dabigatran, Rivaroxaban, and Apixaban
por: Ru San, Tan, et al.
Publicado: (2012)

Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient
por: Yates, Scott W
Publicado: (2013)

Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
por: Morais, João, et al.
Publicado: (2016)

Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation
por: Halperin, Jonathan L, et al.
Publicado: (2014)

Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
por: Bisson, Arnaud, et al.
Publicado: (2017)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Pacemakers as Atrial Fibrillation Detectors: Finding Racial Differences and Opportunities for Preventing Stroke
por: Meschia, James F.
Publicado: (2016)

Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
por: Diener, Hans-Christoph, et al.
Publicado: (2016)

Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation
por: Zirlik, Andreas, et al.
Publicado: (2016)

Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?
por: Cao, Lin, et al.
Publicado: (2015)

Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants
por: Purrucker, Jan C., et al.
Publicado: (2020)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
por: Polymeris, Alexandros A., et al.
Publicado: (2021)

Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models
por: Limone, Brendan L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_904rar4sfngr8ccsv4od7pq9lv